<p>Geode Capital Management LLC 在最近向证券交易委员会（SEC）提交的文件中表示，在第四季度将其在 Oscar Health, Inc.（纽约证券交易所代码：OSCR - 免费报告）的股份增加了 2.5%。该基金在此期间购买了额外的 116,430 股后，持有该公司 4,798,313 股股票。截至其最近的 SEC 文件，Geode Capital Management LLC 持有 Oscar Health 1.81% 的股份，价值 68,964,000 美元。</p>
<ul>
<li>5 只具有爆炸性上涨潜力的小型股</li>
</ul>
<p>其他几家机构投资者和对冲基金也对 OSCR 的持仓进行了调整。美国世纪公司在第三季度将其在 Oscar Health 的持股增加了 89.0%。美国世纪公司现在持有 5,298,340 股该公司的股票，价值 100,298,000 美元，此前在上个季度购买了额外的 2,495,691 股。Farallon Capital Management LLC 在第三季度将其在 Oscar Health 的持股增加了 146.5%。Farallon Capital Management LLC 现在持有 3,639,000 股该公司的股票，价值 68,886,000 美元，此前在上个季度购买了额外的 2,163,000 股。Thrive Capital Management LLC 在第四季度将其在 Oscar Health 的持仓提高了 33.4%。Thrive Capital Management LLC 现在持有 6,343,617 股该公司的股票，价值 85,258,000 美元，此前在此期间购买了额外的 1,588,395 股。Marshall Wace LLP 在第三季度将其在 Oscar Health 的持仓提高了 3,796.6%。Marshall Wace LLP 现在持有 1,137,839 股该公司的股票，价值 21,539,000 美元，此前在此期间购买了额外的 1,108,638 股。最后，Fred Alger Management LLC 在第三季度将其在 Oscar Health 的持仓提高了 225.6%。Fred Alger Management LLC 现在持有 1,212,383 股该公司的股票，价值 22,950,000 美元，此前在此期间购买了额外的 840,038 股。目前，75.70% 的股票由机构投资者和对冲基金持有。</p>
<h2>Oscar Health 股票表现</h2>
<p>纽约证券交易所代码：OSCR 周二开盘价为 27.37 美元。该公司的 50 日简单移动平均线为 18.70 美元，200 日简单移动平均线为 16.16 美元。该公司的市值为 82.5 亿美元，市盈率为 -46.39，市盈增长比率为 1.71，贝塔值为 2.37。该公司的速动比率为 1.11，流动比率为 1.11，债务与股本比率为 0.26。Oscar Health, Inc. 的 52 周最低价为 10.69 美元，52 周最高价为 27.59 美元。</p>
<p>Oscar Health（纽约证券交易所代码：OSCR - 获取免费报告）最近于 5 月 6 日星期三发布了季度财报。该公司报告季度每股收益为 2.07 美元，超出市场共识预期的 1.11 美元，差额为 0.96 美元。该业务在本季度的收入为 46.5 亿美元，而市场共识预期为 49 亿美元。Oscar Health 的净利润率为 -0.30%，股本回报率为 -3.26%。该公司的季度收入较去年同期增长了 52.6%。在去年同期，该公司每股收益为 0.92 美元。整体来看，股票分析师预计 Oscar Health, Inc. 在本财年将发布 0.47 美元的每股收益。</p>
<h2>华尔街分析师预测增长</h2>
<p>几家研究公司最近对 OSCR 发表了评论。Zacks Research 在 5 月 7 日的研究报告中将 Oscar Health 的股票评级从 “持有” 上调至 “强力买入”。Raymond James Financial 在 2 月 12 日的研究报告中将 Oscar Health 的股票评级从 “市场表现” 上调至 “跑赢大盘”，并设定了 18.00 美元的目标价。Wall Street Zen 在一份研究报告中将 Oscar Health 的股票评级从 “强力买入” 下调至 “买入”。富国银行在一份研究报告中设定了 Oscar Health 的目标价为 20.00 美元，并给予该公司 “等权重” 评级。最后，瑞银集团在 5 月 7 日的研究报告中将 Oscar Health 的目标价从 15.00 美元上调至 20.00 美元，并给予该公司 “中性” 评级。一位投资分析师对该股票给予了强力买入评级，两位给予了买入评级，八位给予了持有评级，一位给予了卖出评级。根据 MarketBeat 的数据，该股票的平均评级为 “持有”，共识目标价为 20.22 美元。</p>
<p><strong>查看我们最新的 OSCR 股票报告</strong></p>
<h2>内部人士下注</h2>
<p>在关于 Oscar Health 的其他消息中，内部人士 Adam Mcananey 于 6 月 2 日星期二出售了 9,859 股该公司的股票。股票的平均售价为 21.94 美元，总价值为 216,306.46 美元。交易完成后，该内部人士持有 218,096 股公司的股票，价值为 4,785,026.24 美元。这笔交易使其持股减少了 4.32%。该交易已在向 SEC 提交的法律文件中披露，相关信息可在 SEC 网站上查阅。该交易是在预先安排的 10b5-1 交易计划下执行的。出售的目的是为了覆盖与股权奖励归属相关的税款扣缴义务。此外，董事 Mario Schlosser 于 6 月 2 日星期二出售了 34,120 股该公司的股票。股票的平均售价为 21.94 美元，总交易额为 748,592.80 美元。交易完成后，该董事持有 480,866 股公司的股票，价值约为 10,550,200.04 美元。这笔交易使其持股减少了 6.63%。该销售的披露信息可在 SEC 文件中找到。该交易是在预先安排的 10b5-1 交易计划下执行的。出售的目的是为了覆盖与股权奖励归属相关的税款扣缴义务。在过去一个季度中，内部人士已出售 189,660 股公司股票，价值为 4,283,140 美元。公司内部人士持有 25.11% 的公司股票。</p>
<h2>Oscar Health 公司简介</h2>
<p>（免费报告）</p>
<p>Oscar Health 在纽约证券交易所以 OSCR 的股票代码交易，是一家总部位于纽约的科技驱动健康保险公司。该公司由 Mario Schlosser、Joshua Kushner 和 Kevin Nazemi 于 2012 年创立，旨在简化医疗保险覆盖并提升会员体验。Oscar 利用专有的数字平台来简化计划注册、索赔管理和会员支持，在个人、家庭和小型团体保险市场中脱颖而出。</p>
<p>公司的主要产品包括根据《平价医疗法案》提供的交易所内个人和家庭医疗计划、交易所外计划以及医疗保险优势产品。</p>
<h2>推荐故事</h2>
<ul>
<li>我们更看好的五只股票超过 Oscar Health</li>
<li>7 月 4 日之前需要关注的 3 只新催化剂股票</li>
<li>Amprius 内部人士正在出售：投资者应该担心吗？</li>
<li>较弱的美元可能使这 3 只工业股票重新受到关注</li>
<li>向优质股票的市场轮动将使这 3 只 ETF 受益</li>
</ul>
<p><strong>想看看其他对 OSCR 持有的对冲基金吗？</strong> 请访问 HoldingsChannel.com，获取 Oscar Health, Inc.（NYSE:OSCR - 免费报告）的最新 13F 文件和内部交易信息。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU9TQ1I?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU9TQ1I"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Oscar Health 吗？</h2>
<p>在考虑 Oscar Health 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Oscar Health 并不在名单上。</p>
<p>虽然 Oscar Health 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

OSCR

OSCG

OSCX

<p>Geode Capital Management LLC 在第四季度将其在 Oscar Health (NYSE:OSCR) 的持股增加了 2.5%，持有 480 万股，价值 6896 万美元。其他机构如 American Century 和 Farallon Capital 也增加了持股。Oscar Health 最近报告了第一季度每股收益为 2.07 美元，超出预期，收入为 46.5 亿美元。分析师的评级意见不一，平均评级为 “持有”，共识目标价为 20.22 美元</p>

<p>Geode Capital Management LLC lifted its stake in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) by 2.5% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 4,798,313 shares of the company's stock after purchasing an additional 116,430 shares during the period. Geode Capital Management LLC owned 1.81% of Oscar Health worth $68,964,000 as of its most recent SEC filing.</p>
<div class="lb-trans"><p>Geode Capital Management LLC 在最近向证券交易委员会（SEC）提交的文件中表示，在第四季度将其在 Oscar Health, Inc.（纽约证券交易所代码：OSCR - 免费报告）的股份增加了 2.5%。该基金在此期间购买了额外的 116,430 股后，持有该公司 4,798,313 股股票。截至其最近的 SEC 文件，Geode Capital Management LLC 持有 Oscar Health 1.81% 的股份，价值 68,964,000 美元。</p>
</div><ul>
<li>5 Small Cap Stocks With Explosive Upside Potential</li>
</ul>
<div class="lb-trans"><ul>
<li>5 只具有爆炸性上涨潜力的小型股</li>
</ul>
</div><p>Several other institutional investors and hedge funds have also made changes to their positions in OSCR. American Century Companies Inc. boosted its holdings in shares of Oscar Health by 89.0% during the 3rd quarter. American Century Companies Inc. now owns 5,298,340 shares of the company's stock worth $100,298,000 after purchasing an additional 2,495,691 shares during the last quarter. Farallon Capital Management LLC boosted its holdings in shares of Oscar Health by 146.5% during the 3rd quarter. Farallon Capital Management LLC now owns 3,639,000 shares of the company's stock worth $68,886,000 after purchasing an additional 2,163,000 shares during the last quarter. Thrive Capital Management LLC raised its position in shares of Oscar Health by 33.4% during the 4th quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company's stock valued at $85,258,000 after buying an additional 1,588,395 shares during the period. Marshall Wace LLP raised its position in shares of Oscar Health by 3,796.6% during the 3rd quarter. Marshall Wace LLP now owns 1,137,839 shares of the company's stock valued at $21,539,000 after buying an additional 1,108,638 shares during the period. Finally, Fred Alger Management LLC raised its position in shares of Oscar Health by 225.6% during the 3rd quarter. Fred Alger Management LLC now owns 1,212,383 shares of the company's stock valued at $22,950,000 after buying an additional 840,038 shares during the period. 75.70% of the stock is currently owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>其他几家机构投资者和对冲基金也对 OSCR 的持仓进行了调整。美国世纪公司在第三季度将其在 Oscar Health 的持股增加了 89.0%。美国世纪公司现在持有 5,298,340 股该公司的股票，价值 100,298,000 美元，此前在上个季度购买了额外的 2,495,691 股。Farallon Capital Management LLC 在第三季度将其在 Oscar Health 的持股增加了 146.5%。Farallon Capital Management LLC 现在持有 3,639,000 股该公司的股票，价值 68,886,000 美元，此前在上个季度购买了额外的 2,163,000 股。Thrive Capital Management LLC 在第四季度将其在 Oscar Health 的持仓提高了 33.4%。Thrive Capital Management LLC 现在持有 6,343,617 股该公司的股票，价值 85,258,000 美元，此前在此期间购买了额外的 1,588,395 股。Marshall Wace LLP 在第三季度将其在 Oscar Health 的持仓提高了 3,796.6%。Marshall Wace LLP 现在持有 1,137,839 股该公司的股票，价值 21,539,000 美元，此前在此期间购买了额外的 1,108,638 股。最后，Fred Alger Management LLC 在第三季度将其在 Oscar Health 的持仓提高了 225.6%。Fred Alger Management LLC 现在持有 1,212,383 股该公司的股票，价值 22,950,000 美元，此前在此期间购买了额外的 840,038 股。目前，75.70% 的股票由机构投资者和对冲基金持有。</p>
</div><h2>Oscar Health Stock Performance</h2>
<div class="lb-trans"><h2>Oscar Health 股票表现</h2>
</div><p>NYSE:OSCR opened at $27.37 on Tuesday. The company has a fifty day simple moving average of $18.70 and a two-hundred day simple moving average of $16.16. The company has a market cap of $8.25 billion, a price-to-earnings ratio of -46.39, a price-to-earnings-growth ratio of 1.71 and a beta of 2.37. The company has a quick ratio of 1.11, a current ratio of 1.11 and a debt-to-equity ratio of 0.26. Oscar Health, Inc. has a 52 week low of $10.69 and a 52 week high of $27.59.</p>
<div class="lb-trans"><p>纽约证券交易所代码：OSCR 周二开盘价为 27.37 美元。该公司的 50 日简单移动平均线为 18.70 美元，200 日简单移动平均线为 16.16 美元。该公司的市值为 82.5 亿美元，市盈率为 -46.39，市盈增长比率为 1.71，贝塔值为 2.37。该公司的速动比率为 1.11，流动比率为 1.11，债务与股本比率为 0.26。Oscar Health, Inc. 的 52 周最低价为 10.69 美元，52 周最高价为 27.59 美元。</p>
</div><p>Oscar Health (NYSE:OSCR - Get Free Report) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $2.07 EPS for the quarter, topping the consensus estimate of $1.11 by $0.96. The business had revenue of $4.65 billion during the quarter, compared to the consensus estimate of $4.90 billion. Oscar Health had a negative net margin of 0.30% and a negative return on equity of 3.26%. The company's quarterly revenue was up 52.6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.92 earnings per share. As a group, equities analysts anticipate that Oscar Health, Inc. will post 0.47 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>Oscar Health（纽约证券交易所代码：OSCR - 获取免费报告）最近于 5 月 6 日星期三发布了季度财报。该公司报告季度每股收益为 2.07 美元，超出市场共识预期的 1.11 美元，差额为 0.96 美元。该业务在本季度的收入为 46.5 亿美元，而市场共识预期为 49 亿美元。Oscar Health 的净利润率为 -0.30%，股本回报率为 -3.26%。该公司的季度收入较去年同期增长了 52.6%。在去年同期，该公司每股收益为 0.92 美元。整体来看，股票分析师预计 Oscar Health, Inc. 在本财年将发布 0.47 美元的每股收益。</p>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>华尔街分析师预测增长</h2>
</div><p>Several research firms have recently commented on OSCR. Zacks Research raised shares of Oscar Health from a &#34;hold&#34; rating to a &#34;strong-buy&#34; rating in a research report on Thursday, May 7th. Raymond James Financial raised shares of Oscar Health from a &#34;market perform&#34; rating to an &#34;outperform&#34; rating and set a $18.00 price target on the stock in a research report on Thursday, February 12th. Wall Street Zen lowered shares of Oscar Health from a &#34;strong-buy&#34; rating to a &#34;buy&#34; rating in a research report on Saturday. Wells Fargo &amp; Company set a $20.00 price target on shares of Oscar Health and gave the company an &#34;equal weight&#34; rating in a research report on Thursday. Finally, UBS Group lifted their price target on shares of Oscar Health from $15.00 to $20.00 and gave the company a &#34;neutral&#34; rating in a research report on Thursday, May 7th. One investment analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock has an average rating of &#34;Hold&#34; and a consensus target price of $20.22.</p>
<div class="lb-trans"><p>几家研究公司最近对 OSCR 发表了评论。Zacks Research 在 5 月 7 日的研究报告中将 Oscar Health 的股票评级从 “持有” 上调至 “强力买入”。Raymond James Financial 在 2 月 12 日的研究报告中将 Oscar Health 的股票评级从 “市场表现” 上调至 “跑赢大盘”，并设定了 18.00 美元的目标价。Wall Street Zen 在一份研究报告中将 Oscar Health 的股票评级从 “强力买入” 下调至 “买入”。富国银行在一份研究报告中设定了 Oscar Health 的目标价为 20.00 美元，并给予该公司 “等权重” 评级。最后，瑞银集团在 5 月 7 日的研究报告中将 Oscar Health 的目标价从 15.00 美元上调至 20.00 美元，并给予该公司 “中性” 评级。一位投资分析师对该股票给予了强力买入评级，两位给予了买入评级，八位给予了持有评级，一位给予了卖出评级。根据 MarketBeat 的数据，该股票的平均评级为 “持有”，共识目标价为 20.22 美元。</p>
</div><p><strong>Check Out Our Latest Stock Report on OSCR</strong></p>
<div class="lb-trans"><p><strong>查看我们最新的 OSCR 股票报告</strong></p>
</div><h2>Insiders Place Their Bets</h2>
<div class="lb-trans"><h2>内部人士下注</h2>
</div><p>In other Oscar Health news, insider Adam Mcananey sold 9,859 shares of the business's stock in a transaction on Tuesday, June 2nd. The shares were sold at an average price of $21.94, for a total value of $216,306.46. Following the completion of the transaction, the insider owned 218,096 shares in the company, valued at $4,785,026.24. The trade was a 4.32% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Mario Schlosser sold 34,120 shares of the business's stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $21.94, for a total transaction of $748,592.80. Following the completion of the transaction, the director owned 480,866 shares of the company's stock, valued at approximately $10,550,200.04. This trade represents a 6.63% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last quarter, insiders have sold 189,660 shares of company stock valued at $4,283,140. Corporate insiders own 25.11% of the company's stock.</p>
<div class="lb-trans"><p>在关于 Oscar Health 的其他消息中，内部人士 Adam Mcananey 于 6 月 2 日星期二出售了 9,859 股该公司的股票。股票的平均售价为 21.94 美元，总价值为 216,306.46 美元。交易完成后，该内部人士持有 218,096 股公司的股票，价值为 4,785,026.24 美元。这笔交易使其持股减少了 4.32%。该交易已在向 SEC 提交的法律文件中披露，相关信息可在 SEC 网站上查阅。该交易是在预先安排的 10b5-1 交易计划下执行的。出售的目的是为了覆盖与股权奖励归属相关的税款扣缴义务。此外，董事 Mario Schlosser 于 6 月 2 日星期二出售了 34,120 股该公司的股票。股票的平均售价为 21.94 美元，总交易额为 748,592.80 美元。交易完成后，该董事持有 480,866 股公司的股票，价值约为 10,550,200.04 美元。这笔交易使其持股减少了 6.63%。该销售的披露信息可在 SEC 文件中找到。该交易是在预先安排的 10b5-1 交易计划下执行的。出售的目的是为了覆盖与股权奖励归属相关的税款扣缴义务。在过去一个季度中，内部人士已出售 189,660 股公司股票，价值为 4,283,140 美元。公司内部人士持有 25.11% 的公司股票。</p>
</div><h2>Oscar Health Company Profile</h2>
<div class="lb-trans"><h2>Oscar Health 公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.</p>
<div class="lb-trans"><p>Oscar Health 在纽约证券交易所以 OSCR 的股票代码交易，是一家总部位于纽约的科技驱动健康保险公司。该公司由 Mario Schlosser、Joshua Kushner 和 Kevin Nazemi 于 2012 年创立，旨在简化医疗保险覆盖并提升会员体验。Oscar 利用专有的数字平台来简化计划注册、索赔管理和会员支持，在个人、家庭和小型团体保险市场中脱颖而出。</p>
</div><p>The company's primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.</p>
<div class="lb-trans"><p>公司的主要产品包括根据《平价医疗法案》提供的交易所内个人和家庭医疗计划、交易所外计划以及医疗保险优势产品。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推荐故事</h2>
</div><ul>
<li>Five stocks we like better than Oscar Health</li>
<li>3 Stocks With Fresh Catalysts to Watch Before the July 4</li>
<li>Amprius Insiders Are Selling: Should Investors Be Worried?</li>
<li>A Weaker Dollar Could Put These 3 Industrial Stocks Back in Focus</li>
<li>A Market Rotation Toward Quality Will Benefit These 3 ETFs</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票超过 Oscar Health</li>
<li>7 月 4 日之前需要关注的 3 只新催化剂股票</li>
<li>Amprius 内部人士正在出售：投资者应该担心吗？</li>
<li>较弱的美元可能使这 3 只工业股票重新受到关注</li>
<li>向优质股票的市场轮动将使这 3 只 ETF 受益</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding OSCR?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oscar Health, Inc. (NYSE:OSCR - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他对 OSCR 持有的对冲基金吗？</strong> 请访问 HoldingsChannel.com，获取 Oscar Health, Inc.（NYSE:OSCR - 免费报告）的最新 13F 文件和内部交易信息。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU9TQ1I" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=OSCR"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Oscar Health Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Oscar Health 吗？</h2>
</div><p>Before you consider Oscar Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Oscar Health 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Oscar Health 并不在名单上。</p>
</div><p>While Oscar Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Oscar Health 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Oscar Health, Inc. $OSCR Shares Acquired by Geode Capital Management LLC

Market Beat

Oscar Health

Leverage Shares 2X Long OSCR Daily ETF

Defiance Daily Target 2x Long OSCR ETF

瑞杰金融

富国银行

瑞银集团

RAYMOND JAMES FINANCIAL INC 6.375%DEP SHS REP 1/40TH FXD FLTG SER B

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A DD

WELLS FARGO & COMPANY 7.5% PERP CONV PRF CLS 'A' SERIES 'L'

WELLS FARGO & COMPANY DEP SHS REP 1/1000 INT PER PFD SER Y A

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A CC

WELLS FARGO & COMPANY 4.75% DEP SHS 1/1000 NCUM PFD CL A SR Z

WELLS FARGO & COMPANY DEP SHS REP 1/1000TH INT PFD SR AA (CLA)

Oscar Health, Inc. $OSCR 的股票被 Geode Capital Management LLC 收购